AA
CEROW

AQR Arbitrage’s CERo Therapeutics Warrants CEROW Stock Holding History

AQR Arbitrage’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-246,696
Closed -$5.8K – 644
2023
Q4 		$5.8K Hold
246,696
– – ﹤0.01% 564
2023
Q3 		$17.7K Hold
246,696
– – ﹤0.01% 545
2023
Q2 		$15.1K Sell
246,696
-286
-0.1% -$12 ﹤0.01% 642
2023
Q1 		$12.3K Sell
246,982
-3,016
-1% -$136 ﹤0.01% 832
2022
Q4 		$9.82K Hold
249,998
– – ﹤0.01% 940
2022
Q3 		$20K Hold
249,998
– – ﹤0.01% 1000
2022
Q2 		$25K Hold
249,998
– – ﹤0.01% 1041
2022
Q1 		$54K Hold
249,998
– – ﹤0.01% 892
2021
Q4 		$2.48M Buy
+249,998
New +$115K 0.06% 335

Other funds holding CEROW

HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return

AQR Arbitrage's CEROW Position: Q1 2024 in Review

AQR Arbitrage sold out of CERo Therapeutics Warrants (CEROW) in Q1 2024, closing a stake of 246,696 shares — an estimated $5.8K sold.

AQR Arbitrage first reported a position in CEROW in Q4 2021 and held it in 9 quarters. The position peaked at $2.48M in Q4 2021. 37 funds tracked by Wall St. Rank hold CEROW as of Q1 2024.

  • AQR Arbitrage reported no remaining CERo Therapeutics Warrants position as of Q1 2024 after selling out during the quarter.
  • AQR Arbitrage sold 246,696 CERo Therapeutics Warrants shares in Q1 2024, an estimated $5.8K.
  • AQR Arbitrage first reported a position in CERo Therapeutics Warrants in Q4 2021 and held it in 9 quarters.
  • AQR Arbitrage's CERo Therapeutics Warrants position peaked at $2.48M in Q4 2021.
  • 37 funds tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q1 2024.

Based on AQR Arbitrage's 13F filing for Q1 2024, filed 15 May 2024.